50090-2340 : Odefsey Oral Tablet


NDC: 50090-2340
Labeler: A-s Medication Solutions
Product Type: Human Prescription Drug
Drug Name:  Odefsey
Dosage Form: Oral Tablet
Application #: NDA208351
Rev. Date: 


Appearance:


Markings: GSI;255
Shapes:  Oval
Colors:  Gray
Size (mm): 15
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

NDC Package Codes:

  • 50090-2340-0: 30 TABLET IN 1 BOTTLE, PLASTIC (50090‑2340‑0)

Active Ingredients:

  • Emtricitabine
  • Rilpivirine Hydrochloride
  • Tenofovir Alafenamide Fumarate

Dosage Strength:

  • 200 mg
  • 25 mg
  • 25 mg

Inactive Ingredients:

  • Lactose Monohydrate
  • Cellulose, Microcrystalline
  • Povidones
  • Polysorbate 20
  • Croscarmellose Sodium
  • Magnesium Stearate
  • Water
  • Polyvinyl Alcohol
  • Titanium Dioxide
  • Polyethylene Glycols
  • Talc
  • Ferrosoferric Oxide

Pharmaceutical Classes:

  • Nucleoside Analog [EXT]
  • Nucleoside Reverse Transcriptase Inhibitors [MoA]
  • Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
  • Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
  • Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]
  • Non-Nucleoside Analog [EXT]
  • Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]

Related Products:

Based on records with the same trade name.
  • 61958-2101 Odefsey Oral Tablet by Gilead Sciences, Inc.
  • 70518-0695 Odefsey Oral Tablet by Remedyrepack Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 50090-2340 QR Code

< Prev: 50090-2339Next: 50090-2341 >

Related Discussions:

Tenofovir with primolut N
Actually I am taking tenofovir from the past 2 years. Now I need to take primolut N. Can I take it with tenofovir? One o...




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.